Cohort (n = 150) | DP (n = 124) | DFTR (n = 26) | P | |
---|---|---|---|---|
Laterality of diaphragm lesions (%) | ||||
Right | 95 (63.3%) | 78 (62.9%) | 17 (65.4%) | 0.811 |
Left | 1 (0.7%) | 1 (0.8%) | 0 | |
Bilateral | 54 (36.0%) | 45 (36.3%) | 9 (34.6%) | |
Perforation into pleural cavity (%) | 65 (43.3%) | 39 (31.5%) | 26 (100%) | <0.001 |
TDDE (%) | 34 (22.7%) | 21 (16.9%) | 13 (50.0%) | <0.001 |
Pleural nodule biopsy performed (%) | 21 (14.0%) | 15 (12.1%) | 6 (23.1%) | 0.248 |
Prophylactic chest tube placement (%) | 8 (5.3%) | 5 (4.0%) | 3 (11.5%) | 0.285 |
Mesh utilization in diaphragm repair (%) | 4 (2.7%) | 0 | 4 (15.4%) | <0.001 |
Extended procedures performed (%) | ||||
Small bowel resection | 5 (3.3%) | 5 (4.0%) | 0 | 0.660 |
Large bowel resection | 48 (32.0%) | 37 (29.8%) | 11 (42.3%) | 0.215 |
Splenectomy | 18 (12.0%) | 14 (11.3%) | 4 (15.4%) | 0.801 |
Partial pancreatectomy | 5 (3.3%) | 4 (3.2%) | 1 (3.8%) | 1.000 |
Partial hepatic resection | 4 (2.7%) | 4 (3.2%) | 0 | 0.796 |
Resection of porta hepatis tumor | 4 (2.7%) | 3 (2.4%) | 1 (3.8%) | 1.000 |
Cholecystectomy | 1 (0.7%) | 1 (0.8%) | 0 | 1.000 |
Stomia | 15 (10.0%) | 12 (9.7%) | 3 (11.5%) | 1.000 |
Resection of the tumor on the liver surface | 23 (15.3%) | 20 (16.1%) | 3 (11.5%) | 0.771 |
Resection of the tumor on the stomach surface | 13 (8.7%) | 10 8.1(%) | 3 (11.5%) | 0.850 |
Resection of the tumor in the gallbladder fossa | 6 (4.0%) | 6 (4.8%) | 0 | 0.552 |
Residual disease (%) | ||||
Complete cytoreduction | 53 (35.3%) | 42 (33.9%) | 11 (42.3%) | 0.649 |
Residual disease ≤1 cm | 73 (48.7%) | 61 (49.2%) | 12 (46.2%) | |
Median operation time (range), minutes | 180 (60–330) | 180 (60–330) | 195 (90–270) | 0.576 |
Median EBL (range), mL | 900 (100–5300) | 900 (100–5300) | 1000 (200–2200) | 0.802 |
Intraoperative blood transfusion (%) | 132 (88%) | 109 (87.9%) | 23 (88.5%) | 0.937 |
Median transfusion amount (range), units | 4.0 (1.0–15.0) | 4.5 (1–15) | 4 (2–13) | 0.286 |
Planned intensive care unit stay (%) | 46 (30.7%) | 39 (30.6%) | 8 (30.8%) | 0.649 |
Median time interval from surgery to chemotherapy (range), days | 14 (6–40) | 14 (6–40) | 14 (6–34) | 0.272 |